Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au, Steven Park, Andrew Z. Wang
Science Advances (2020) Vol. 6, Iss. 27
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 140
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 69
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 45
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Yuan‐Bo Pan, Wei Tang, Wenpei Fan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 23, pp. 9759-9830
Open Access | Times Cited: 68
Antibody‐Incorporated Nanomedicines for Cancer Therapy
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 66
Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
Zhoujiang Chen, Ranjith Kumar Kankala, Zhiyong Yang, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3719-3746
Open Access | Times Cited: 53
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
Mengying Hu, Leaf Huang
Advanced Drug Delivery Reviews (2022) Vol. 183, pp. 114137-114137
Open Access | Times Cited: 42
T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems
Yalong Yang, Fei Yang, Zhuan-qing Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Polymer Micropatches as Natural Killer Cell Engagers for Tumor Therapy
Supriya Prakash, Ninad Kumbhojkar, Andrew Lu, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15918-15930
Closed Access | Times Cited: 25
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
Minchuan Zhang, Kong‐Peng Lam, Shengli Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 23
Tuning Surface Valences of Nanoengagers to Enhance Their Structural Advantages for Efficiently Redirecting T Cells against Solid Tumors
Zichao Huang, Liping Liu, Zhenyi Zhu, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Nanomedicine in Immunotherapy for Non‐Small Cell Lung Cancer: Applications and Perspectives
Shuangsi Liao, Xiaoling Li, You Lü, et al.
Small Methods (2025)
Open Access | Times Cited: 1
Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development
Ming Li, Bingjie Hao, Menghuan Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 53
Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury
Li Luo, Guangchao Zang, Boyan Liu, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8043-8056
Open Access | Times Cited: 45
Immune cell targeting nanoparticles: a review
Na Kyeong Lee, Se−Na Kim, Chun Gwon Park
Biomaterials Research (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 45
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Meihua Yu, Wei Yang, Wenwen Yue, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 38
MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers
Jie Liu, Jie Yang, Qilong Pan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
Idoia Mikelez-Alonso, Susana Magadán, África González‐Fernández, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113860-113860
Closed Access | Times Cited: 40
Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy
Qian‐Ni Ye, Yue Wang, Song Shen, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 11
Closed Access | Times Cited: 38
Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy
Christine Boone, Lu Wang, Aayushma Gautam, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
Jun Gu, Gang Zhao, Jiangkun Yu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top